Skip to content
  • Home
  • About
  • News
    • Top
    • Recent News
    • Archive
  • Account
    • Profile
    • Manage Corporate Account
    • Orders
    • Billing
    • Cancel
  • Subscription Plans
  • Contact
  • Login
  • Home
  • About
  • News
    • Top
    • Recent News
    • Archive
  • Account
    • Profile
    • Manage Corporate Account
    • Orders
    • Billing
    • Cancel
  • Subscription Plans
  • Contact
  • Login

Unregulated Glucose Monitors Pose Risk to Diabetics

Discover the implications of using unregulated glucose monitors and the urgent need for safety standards in diabetes care.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

African Form of Type 1 Diabetes Challenges Old Beliefs

An African form of type 1 diabetes challenges existing beliefs about the autoimmune response and its management.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Childhood Obesity: Addressing Lifestyle Diseases Early

Discover the alarming rise of childhood obesity in South Africa and its link to lifestyle diseases and poor eating habits.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Ghana’s Diabetes Crisis: A Public Health Emergency

Understand Ghana's diabetes crisis, where 2.4 million people face daily challenges due to inadequate health infrastructure.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Ozempic and Mounjaro are reshaping South Africa’s health market

Understand the significance of Ozempic and Mounjaro in the evolving landscape of diabetes care and weight management in South Africa.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

SA’s HIV success story creates new challenges

Explore SA's HIV success story: a transformative treatment programme that increases life expectancy and faces new health challenges.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Lilly’s Orforglipron Shows Significant Weight Loss in Phase 3 Trial

Orforglipron can offer a new oral option for managing weight loss and blood sugar in type 2 diabetes treatment.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Competition Commission probes insulin price fixing

The Competition Commission is investigating insulin manufacturers Novo Nordisk and Sanofi Aventis, raising concerns about accessibility to diabetes care.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
← Previous